Update on PSMA PET/CT in Prostate Cancer and the Unmet Need for Imaging of RCC

In this webinar, attendees will learn how advanced imaging with 68Gallium PSMA 11 enhances clinical decision-making in prostate cancer. Attendees will also examine diagnostic PET/CT in renal cancer utilizing 89Zr-girentuximab as evidenced by the ZIRCON study.

Daniel D. Joyce, MD, MS

Dr. Daniel D. Joyce is at Urology Vanderbilt Nashville. He attended Mayo Medical School, completed his residency at Vanderbilt University Medical Center, and completed a fellowship at the Mayo Clinic in Rochester, Minnesota. His clinical interests are kidney cancer, testis cancer, bladder cancer, prostate cancer, and genitourinary cancer.

Jaideep Sohi, MD

Dr. Jaideep S. Sohi is a Johns Hopkins fellowship-trained PET CT specialist with over 5 years of experience. He currently serves as the president of American Molecular Imaging, and also serves as clinical faculty at Northwestern Department of Radiology.

Update on PSMA PET/CT in Prostate Cancer and the Unmet Need for Imaging of RCC

Duration

00:35:51

Event Details